Grant: Strategic Projects - Group
McGill University
$57,132.00
Low temperature bioactive magnesium phosphate coatings
FY 2009-10
Summary
This strategic research project funded by NSERC is a collaborative effort between one of Canada's top
Universities - McGill and a leading Canadian internal fixation device manufacturer - Terray Corporation.
It has been known for a century that magnesium and its biological corrosion products are non toxic, enhance
bone formation and support osteoblast differentiation and function, yet no commercial product based on this
well established technology exist. The reason for this is that the previous aim was to create degradable load
bearing bone fixation plates which was highly ambitious and fraught with difficulties stemming from a lack of
knowledge concerning the inorganic phosphate degradation products and biological responses to these
materials (about which the PI specialises). Our aim is to build on the wealth of knowledge accumulated in
these prior studies to develop new osteoconductive coatings for bone fixation plates, matrices for delivery of
therapeutic molecules from these coatings and to examine more systematically the role that these phosphate
corrosion products have in controlling the rate of biological degradation of magnesium based devices.
This research will help to maintain Terray's position as a global leader in biomedical engineering innovation.
Improved fracture fixation and reduced patient recovery times are the main anticipated benefits of this research.
Program
Strategic Projects - Group
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
336876-2006
Name nom
Barralet, Jake
Department département
Dentistry, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2006
Award amount
57132
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
3
Nb partie
3
Application title
Low temperature bioactive magnesium phosphate coatings
Keyword
NA
Application summary
This strategic research project funded by NSERC is a collaborative effort between one of Canada's top
Universities - McGill and a leading Canadian internal fixation device manufacturer - Terray Corporation.
It has been known for a century that magnesium and its biological corrosion products are non toxic, enhance
bone formation and support osteoblast differentiation and function, yet no commercial product based on this
well established technology exist. The reason for this is that the previous aim was to create degradable load
bearing bone fixation plates which was highly ambitious and fraught with difficulties stemming from a lack of
knowledge concerning the inorganic phosphate degradation products and biological responses to these
materials (about which the PI specialises). Our aim is to build on the wealth of knowledge accumulated in
these prior studies to develop new osteoconductive coatings for bone fixation plates, matrices for delivery of
therapeutic molecules from these coatings and to examine more systematically the role that these phosphate
corrosion products have in controlling the rate of biological degradation of magnesium based devices.
This research will help to maintain Terray's position as a global leader in biomedical engineering innovation.
Improved fracture fixation and reduced patient recovery times are the main anticipated benefits of this research.